These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 21120602

  • 1. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.
    Paruthiyil S, Cvoro A, Tagliaferri M, Cohen I, Shtivelman E, Leitman DC.
    Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602
    [Abstract] [Full Text] [Related]

  • 2. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
    Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST.
    Anticancer Res; 2006 Nov; 26(2A):1097-104. PubMed ID: 16619512
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 5. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT, Huang KY, Lin HY, Chung JG.
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [Abstract] [Full Text] [Related]

  • 6. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Jul; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 7. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM, Brokken LJ, Narvi E, Kallio MJ, Härkönen PL.
    Mol Cell Endocrinol; 2012 Jul 06; 358(1):104-15. PubMed ID: 22465097
    [Abstract] [Full Text] [Related]

  • 8. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK.
    Exp Cell Res; 2004 Sep 10; 299(1):159-70. PubMed ID: 15302583
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.
    Knight GL, Turnell AS, Roberts S.
    J Virol; 2006 Aug 10; 80(15):7416-26. PubMed ID: 16840322
    [Abstract] [Full Text] [Related]

  • 11. Citrate-Induced p85α⁻PTEN Complex Formation Causes G2/M Phase Arrest in Human Pharyngeal Squamous Carcinoma Cell Lines.
    Hung KC, Wang SG, Lin ML, Chen SS.
    Int J Mol Sci; 2019 Apr 29; 20(9):. PubMed ID: 31035650
    [Abstract] [Full Text] [Related]

  • 12. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
    Donato LJ, Suh JH, Noy N.
    Cancer Res; 2007 Jan 15; 67(2):609-15. PubMed ID: 17234770
    [Abstract] [Full Text] [Related]

  • 13. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
    Yang H, Cai YC, Pang JY, Li YQ, Zeng ZL, Xu ZL, Xian LJ.
    Yao Xue Xue Bao; 2008 Feb 15; 43(2):138-44. PubMed ID: 18507339
    [Abstract] [Full Text] [Related]

  • 14. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
    Zhang Z, Chen C, Wang G, Yang Z, San J, Zheng J, Li Q, Luo X, Hu Q, Li Z, Wang D.
    Cell Biochem Biophys; 2011 Sep 15; 61(1):83-91. PubMed ID: 21327578
    [Abstract] [Full Text] [Related]

  • 15. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
    Choi EJ, Kim GH.
    J Nutr Biochem; 2009 Apr 15; 20(4):285-90. PubMed ID: 18656338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y, Buffolino P, Coppock DL.
    Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525
    [Abstract] [Full Text] [Related]

  • 19. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
    Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S.
    Cancer Res; 2006 Jul 15; 66(14):7075-82. PubMed ID: 16849553
    [Abstract] [Full Text] [Related]

  • 20. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY.
    Cancer Res; 2000 Feb 01; 60(3):542-5. PubMed ID: 10676633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.